HR 1060
Modern Authentication of Pharmaceuticals Act of 2025
Summary
Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.
Bill status
- Status
- In committee
- Sponsor
- Rep. Donald G. Davis [D-NC-1]
- Cosponsors
- 3
- Policy area
- Health
- Introduced
- 2025-02-06
- Latest action
- 2025-02-06: Referred to the House Committee on Energy and Commerce.
Committee referrals
Recent actions
- 2025-02-06: Referred to the House Committee on Energy and Commerce.
- 2025-02-06: Introduced in House
- 2025-02-06: Sponsor introductory remarks on measure. (CR H519)
- 2025-02-06: Introduced in House